TP53 and leukemia: Consistently, infiltration by GFP-positive AML cells was decreased within 3 days in both p53+/+ and E177R spleens, confirming that E177R was not only acting in a cytostatic manner by cell cycle inhibition, but was also effectively eliminating leukemia cells (Fig. 6C).